Molecular pathology and pathobiology of osteoarthritic cartilage

Cellular and Molecular Life Sciences

Volumn 59, Issue 1, 2002, Pages 5-18

  Aigner, T ^a   McKenna, L ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Apoptosis; Cartilage; CDNA array; Collagen; MRNA expression; Osteoarthritis; Proteoglycan

Indexed keywords

COLLAGEN; PROTEOGLYCAN;

ARTICULAR CARTILAGE; CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CELL PROLIFERATION; DISEASE ASSOCIATION; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; JOINT FUNCTION; OSTEOARTHRITIS; PHENOTYPE; REVIEW; SUPRAMOLECULAR CHEMISTRY;

ANIMALS; APOPTOSIS; CARTILAGE, ARTICULAR; CELL DIVISION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; HUMANS; NECROSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS; PHENOTYPE; RNA, MESSENGER;

EID: 0036161569     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8400-3     Document Type: Review

References (135)

1. Relationship of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover
2. Mechanisms involved in cartilage proteoglycan catabolism
3. The chondrocyte, architect of cartilage
4. Structure and function of cartilage collagens
5. Chondrons from articular cartilage. I. Immunolocalization of type VI collagen in the pericellular capsule of isolated canine tibial chondrons
6. Chondrons from articular cartilage. V. Immunohistochemical evaluation of type VI collagen organisation in isolated chondrons by light, confocal and electron microscopy
7. Severe disturbance of the distribution and expression of type VI collagen chains in osteoarthritic articular cartilage
8. Balance between swelling pressure and collagen tension in normal and degenerate cartilage
9. The structure and function of cartilage proteoglycans
10. Negative regulation of transforming growth factor-β by the proteoglycan decorin
11. Binding of fibromodulin and decorin to separate sites on fibrillar collagens
12. Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped: Implications for their interactions with collagen
13. Articular cartilage morphology
14. Differences between sub-populations of cultured bovine articular chondrocytes. I. Morphology and cartilage matrix production
15. Differences between sub-populations of cultured bovine articular chondrocytes. II. Proteoglycan metabolism
16. Proteoglycans of articular cartilage: Changes in aging and in joint disease
17. Age-related changes in cartilage proteoglycans: Quantitative electron microscopic studies
18. Link protein as a monitor in situ of endogenous proteolysis in adult human articular cartilage
19. The structure of aggrecan and its turnover in cartilage
20. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro
21. Generation and characterization of aggrecanase
22. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4)
23. Extracellular metabolism of aggrecan
24. Aggrecan turnover in human articular cartilage: Use of aspartic acid racemization as a marker of molecular age
25. Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage
26. The regulation of MMPs and TIMPs in cartilage turnover
27. Enhanced cleavage of type Ii collagen by collagenase in osteoarthritic articular cartilage
28. Biochemical and metabolic abnormalities in articular carti-lage from osteo-arthritic human hips
29. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips
30. A simplified measurement of degraded collagen in tissues: Application in healthy, fibrillated and osteoarthritic cartilage
31. Immunohistochemical detection and immunohistochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1
32. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage
33. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage
34. Osteoarthritic lesions - Involvement of three different collagenases
35. Chondrocyte matrix metalloproteinase-8: Up-regulation of neutrophil collagenase by interleukin-1 in human cartilage from knee and ankle joints
36. The structure of aggrecan fragments in human synovial fluid - Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis
37. ADAM-10 message is expressed in human articular cartilage
38. Upregulation of MDC 15 (matargidin) mRNA in human osteoarthritic cartilage
39. Tenascin is increased in cartilage and synovium from osteoarthritic knees
40. Reexpression of procollagen type IIA by adult articular chondrocytes in osteoarthritis cartilage
41. Independent expression of fibril-forming collagens I, II, and III in chondrocytes in human osteoarthritic cartilage
42. Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies
43. Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamenteous network
44. Comparative analysis of collagens solubilized from human foetal, and normal and osteoarthritic adult articular cartilage, with emphasis on type VI collagen
45. Experimental osteoarthritic articular cartilage is enriched in guanidine-soluble type VI collagen
46. Type VI collagen but not type V collagen is present in cartilage
47. Chondrons from articular cartilage. III. Morphologic changes in the cellular microenvironment of chondrons isolated from osteoarthritic cartilage
48. Increased content of type-VI collagen epitopes in human osteoarthritic cartilage: Quantitation by inhibition ELISA
49. Type VI collagen in extracellular, 100-nm periodic filaments and fibrils: Identification by immunoelecton microscopy
50. Beaded filaments and long-spacing fibrils: Relation to type VI collagen
51. Attachment of articular cartilage chondrocytes to the tissue form of type VI collagen
52. Growth factor regulation of chondrocyte integrins
53. Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI
54. Collagen VI regulates normal and transformed mesenchymal cell proliferation in vitro
55. The pathology of osteoarthritis
56. The interrelationship of cell density and cartilage thickness in mammalian articular cartilage
57. Chondrocyte multiplication in osteoarthritic articular cartilage
58. Mitosis in human articular ostoearthritic cartilage
59. 4) in vitro
60. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration
61. Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage
62. The cell densitiy of human femoral head cartilage
63. Osteoarthritic chondrocytes die by apoptosis
64. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis
65. Apoptotic chondrocyte death in human osteoarthritis
66. Apoptotic chondrocytes from osteoarthrotic human articular cartilage and abnormal calcification of subchondral bone
67. Collagen synthesis in normal and osteoarthrotic human cartilage
68. Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis
69. 4) uptake by chondrocytes in relation to histological changes in osteoarthritic human articular cartilage
70. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. III. Distribution and metabolism of amino sugar-containing macromolecules
71. Metabolism of human femoral head cartilage in osteoarthrosis and subcapital fracture
72. Biochemical and metabolic abnormalities in normal and osteoarthritic human articular cartilage
73. In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis
74. Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage
75. Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis
76. Discoordinate gene expression of aggrecan and type II collagen in experimental osteoarthritis
77. Expression of collagen types IX and XI as well as other major cartilage matrix components by human fetal chondrocytes in vivo
78. Differential expression of collagen types I, II, III, and X in human osteophytes
79. Physicochemical properties of articular cartilage
80. Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: A hypothesis
81. Local changes in proteoglycan synthesis during culture are different for normal and osteoarthritic cartilage
82. Chondrocyte differentiation
83. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture
84. The progeny of rabbit articular chondrocytes synthesize collagen types I and III and type I trimer, but not type II: Verifications by cyanogen bromide peptide analysis
85. Relationship between cell shape and type of collagen synthesized as chondrocytes lose their cartilage phenotype in culture
86. Differentiation, modulation and dedifferentiation of chondrocytes
87. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: Differential expression of the amino-propeptide
88. Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization
89. Immunochemical and biochemical study of collagen synthesis by chondrocytes in culture
90. In situ hybridization studies on the expression of type X collagen in fetal human cartilage
91. Immunohistochemical localization of short chain cartilage collagen (type X) in avian tissues
92. Expression of type-X collagen in osteoarthritis
93. Hypertrophic chondrocytes undergo further differentiation in culture
94. Ascorbate independent differentiation of human chondrocytes in vitro: Simultaneous expression of type I and X collagens and matrix mineralization
95. Osteogenic differentiation of hypertrophic chondrocytes involves asymmetric cell divisions and apoptosis
96. Nucleotide and amino acid sequences of the entire human α1(III) collagen
97. Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms
98. Type IIA procollagen amino pro-peptide is localized in human embryonic tissues
99. A novel proteoglycan synthesized and secreted by chondrocytes of the superficial zone of articular cartilage
100. Cluster analysis and display of genome-wide expression patterns
101. Isolation of RNA from small human articular cartilage specimens allows quantification of mRNA expression levels in local articular cartilage defects
102. Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments
103. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage
104. Membrane type 1 matrix metalloproteinase digests in-terstitial collagens and other extracellular matrix macromolecules
105. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain
106. Aggrecan degradation in human cartilage
107. Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes
108. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: Differential regulation of collagenase 1 and collagenase 3
109. 2 terminal kinase and p38 and I1-1 and TNF in human articular chondrocytes
110. Caspase-dependent cleavage and inactivation of the Vav1 proto-oncogene product during apoptosis prevents IL-2 transcription
111. Evidence for a novel gene associated with low tumor metastatic potential
112. Analysis of differential gene expression in the kidney by differential cDNA screening, subtractive cloning, and mRNA differential display
113. Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis
114. Identification of differentially expressed genes during hepatocytes development and characterization of their prenatal hormonal induction
115. Isolation of cDNA clones corresponding to genes differentially expressed in two colon-carcinoma cell lines differing by their tumorigenicity
116. Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells
117. In vitro cDNA amplification from individual intestinal crypts: A novel approach to the study of differential gene expression along the crypt-villus axis
118. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
119. Effective isolation of high quality total RNA from human adult articular cartilage
120. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA
121. Rapid identification of a novel chondrocyte-specific gene by RNA differential display
122. Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis
123. Complexity of I1-1 beta induced gene expression pattern in human articular chondrocytes
124. Distribution of peptidyl-glycine alpha-amidating mono-oxygenase (PAM) enzymes in normal human lung and in lung epithelial tumors
125. Peptidylglycine alpha-amidating mono-oxygenase: Neuropeptide amidation as a target for drug design
126. Aggrecan, the chondroitin sulfate/keratan sulfate proteoglycan from cartilage
127. Two distinct metabolic pools of proteoglycans in articular cartilage
128. Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: A comparison between the processes of aging and degeneration in human hip cartilage
129. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels
130. The recovery of articular cartilage in explant culture from interleukin-1 alpha: Effects on proteoglycan synthesis and degradation
131. Re-expression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads
132. Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: An experimental study in sheep
133. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation
134. Growth requirements of low-density rabbit costal chondrocyte cultures maintained in serum-free medium
135. Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes